In the published article, there was an error in affiliations 1 and 2. Instead of “1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 2Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China, “, it should be “1Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China, 2Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is notguaranteed or endorsed by the publisher.
Summary
Keywords
DCBLD1, biomarker, immune infiltrates, prognosis, head and neck squamous cell carcinoma
Citation
Fu L, Yan M, Ma M-X, Luo Y, Shao M, Gosau M, Friedrich RE, Vollkommer T, Feng H and Smeets R (2022) Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma. Front. Immunol. 13:1099835. doi: 10.3389/fimmu.2022.1099835
Received
16 November 2022
Accepted
17 November 2022
Published
25 November 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Fu, Yan, Ma, Luo, Shao, Gosau, Friedrich, Vollkommer, Feng and Smeets.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hong-chao Feng, hcfeng@gzu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.